Less cutting, same cure? new trial tests smaller surgery for rectal cancer

NCT ID NCT07038122

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether surgeons can safely remove less tissue during surgery for upper rectal cancer after patients have received pre-surgery therapy. About 874 adults with locally advanced rectal cancer will be randomly assigned to either standard or reduced surgical margins. The goal is to see if the smaller surgery is as effective at preventing cancer from coming back while being safer and easier to recover from.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
laparoscopic surgery with reduced resection margins
What this could lead to
If successful, this could allow surgeons to remove less tissue while still effectively treating rectal cancer, leading to faster recovery and fewer complications.
What could go wrong
This is an early-stage trial with 874 participants, and the reduced margins might not be as effective as standard surgery in preventing cancer return. Risks include surgical complications like leakage or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.